ABT Novinky na Forexe

Abbott Laboratories Boosts FY24 Earnings Outlook - Update

Abbott Laboratories Boosts FY24 Earnings Outlook - Update

While reporting financial results for the second quarter on Thursday, Abbott Laboratories (ABT) provided earnings and adjusted earnings guidance for the third quarter and raised its outlook for the full-year 2024.
RTTNews | Pred 103 dňami
Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor

Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor

Abbott Laboratories (ABT) announced Thursday that its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug Administration (FDA) clearance, giving physicians a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats.
RTTNews | Pred 530 dňami
Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis

Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis

Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis who are at high or extreme risk for open-heart surgery.
RTTNews | Pred 651 dňami